Results 261 to 270 of about 2,291,402 (391)

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

The merit of rural point-of-care ultrasound: Carotid pseudoaneurysm case report. [PDF]

Afr J Prim Health Care Fam Med
Thirion JC, Van Hoving DJ.
europepmc   +1 more source

Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation

Molecular Oncology, EarlyView.
Pericytes alter their transcriptome depending on their proximity to the tumor core. In the tumor core, pericytes display a more active state with higher communication strength but with lower immune activation potential and a shift toward extracellular matrix production.
Carolina Buizza, Robert Carlsson, Coralie Gamper, Gayatri Chitale, Johan Bengzon, Gesine Paul   +5 more
wiley   +1 more source

Evaluation of the user experience for a point of care molecular test for causes of vaginitis. [PDF]

BMC Infect Dis
Van Der Pol B, Lillis R, Nachamkin I, Young S, Crane L, Brown J, Parker RL, Weissfeld A, Liu X, Huang C, Raman A.   +10 more
europepmc   +1 more source

Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women [PDF]

, 2003
Peter Vickerman
openalex   +1 more source

RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR‐targeted therapies

Molecular Oncology, EarlyView.
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha, Joana Pinheiro, Rui F. Marques, Patrícia Fontão, Diana Cardoso‐Carneiro, Adriana Mendes, Izabela N. F. Gomes, Ana Carolina Laus, Renato J. da Silva‐Oliveira, Rui Manuel Reis, Olga Martinho   +10 more
wiley   +1 more source

The potential of salivary point of care diagnostics [PDF]

, 2014
BONEBREAK, Christina M., DEMIRCI, Utkan, KUO, Winston Patrick   +2 more
core   +1 more source

Recent Advances in Aptamer-Based Point-of-Care Testing. [PDF]

Sensors (Basel)
Luo S, Zhang X, Zhang Y, Qu X, Sun Q, Peng T, Yuan Q.   +6 more
europepmc   +1 more source

Evaluation of a New Point-of-care Celite-activated Clotting Time Analyzer in Different Clinical Settings [PDF]

, 2003
Rita Paniccia, Sandra Fedi, Fiorella Carbonetto, Daniela Noferi, Paolo Conti, Brunella Bandinelli, Betti Giusti, L. Evangelisti, Paola Pretelli, Mara F.G. Palmarini, Rosanna Abbate, Domenico Prisco   +11 more
openalex   +1 more source

Salivary point-of-care technology [PDF]

European Journal of Dentistry, 2018
openaire   +3 more sources